Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 301–400 of 1,000
Zhang, Q., Sakamoto, K., & Wagner, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.016 · Cited by 60
Relevance of chromosomal band 11q13 in oral carcinogenesis: An update of current knowledge
Ramos‐García, P., Ruiz‐Ávila, I., Montoya, J. A. G., Ayén, Á., González‐Ruiz, L., Navarro‐Triviño, F. J., & González‐Moles, M. Á. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.04.016 · Cited by 59
Chen, S., Chen, L., Le, N. T., Zhao, C., Sidduri, A., Lou, J. P., Michoud, C., Portland, L., Jackson, N., Liu, J., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.081 · Cited by 57
Shen, F., Chang, H., Gao, G., Zhang, B., Li, X., & Jin, B. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28208 · Cited by 56
“It is well‐known that D‐type cyclins (CCND) have critical roles in the regulation of cell cycle progression.(30) Three D‐type cyclins, cyclin D1, D2, and D3, are encoded by”
BackgroundThe interplay of CDK4 and CDK6 in melanoma
Kollmann, K., Briand, C., Bellutti, F., Schicher, N., Blunder, S., Zojer, M., & Höeller, C. (2019) · Oncotarget · doi:10.18632/oncotarget.26515 · Cited by 59
“These complexes phosphorylate the Retinoblastoma protein (Rb) to regulate transition from G1 to S phase [1] [2].”
BackgroundZeng, L., Fan, X., Wang, X., Deng, H., Zhang, K., Zhang, X., He, S., Li, N., Han, Q., & Liu, Z. (2019) · Current Genomics · doi:10.2174/1389202920666191011092410 · Cited by 62
“Cyclin expression and degradation play an important role in cell mitosis [29], mainly by regulating CDK kinase [30].”
BackgroundTian, K. V., Yang, S., Ren, Q., Han, Z., Lu, S., Ma, F., Zhang, L., & Han, Z. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000323973 · Cited by 61
Bol, V. V., Reusens, B. M., & Remacle, C. A. (2008) · Obesity · doi:10.1038/oby.2008.417 · Cited by 49
“Together with their kinases, these proteins are necessary for entrance and progression through the G1 phase of the cell cycle (15).”
BackgroundRobinson, A. M., Rathore, R., Redlich, N. J., Adkins, D. R., VanArsdale, T. L., Tine, B. A. V., & Michel, L. S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2098-8 · Cited by 57
Cell‐context specific role of the E2F/Rb pathway in development and disease
Swiss, V. A., & Casaccia, P. (2009) · Glia · doi:10.1002/glia.20933 · Cited by 62
“CDKIs can be divided into the Cip/Kip (p21, p27, and p57) and Ink4 (p15, p16, p18, and p19) families, whose expression is tightly coordinated with the proliferative state of the cell (Sherr and Roberts, 1999, 2004).”
BackgroundZidovudine induces S-phase arrest and cell cycle gene expression changes in human cells
Olivero, O. A., Tejera, Á. M., Fernandez, J. J., Taylor, B. J., Das, S., Divi, R. L., & Poirier, M. C. (2005) · Mutagenesis · doi:10.1093/mutage/gei019 · Cited by 56
Functional development of the adult ovine mammary gland—insights from gene expression profiling
Paten, A. M., Duncan, E. J., Pain, S. J., Peterson, S. W., Kenyon, P. R., Blair, H. T., & Dearden, P. K. (2015) · BMC Genomics · doi:10.1186/s12864-015-1947-9 · Cited by 59
“this is reflected in the present study through enrichment of genes associated with: regulation of cell cycle, including cyclins and cyclin-dependent kinases which form complexes to regulate cell cycle progression [51]; DNA synthesis including genes encoding the components of the MCM complex, which form part of the pre…”
BackgroundLong-Term Quiescent Fibroblast Cells Transit into Senescence
Marthandan, S., Priebe, S., Hemmerich, P., Klement, K., & Diekmann, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115597 · Cited by 54
“Quiescent cells show low expression of cyclins and cyclin dependent kinases (CDKs) [6, 16, 17] as well as of the CDK inhibitors (CDKIs) p19 or p16 [1, 18] but high expression of CDKIs p21, p27, p53 and p57 [2].”
BackgroundCell-specific Kaiso (ZBTB33) Regulation of Cell Cycle through Cyclin D1 and Cyclin E1
Pozner, A., Terooatea, T. W., & Buck‐Koehntop, B. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.746370 · Cited by 60
“With sufficient stimulation, activities of cyclin D-Cdk4,6 and cyclin E-Cdk2 complexes are successively induced to phosphorylate RB1 and relieve its repression of E2F (36, 42, 43).”
BackgroundG2E3 Is a Dual Function Ubiquitin Ligase Required for Early Embryonic Development
Brooks, W. S., Helton, E. S., Banerjee, S., Venable, M., Johnson, L., Schoeb, T. R., Kesterson, R. A., & Crawford, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803238200 · Cited by 59
Neurauter, C. G., Luna, L., & Bjørås, M. (2012) · DNA repair · doi:10.1016/j.dnarep.2012.01.007 · Cited by 61
Zhou, W., Yang, Q., Low, C. B., Chandrababu, K. B., Wang, Y., Ryo, A., Yao, S. Q., Yang, D., & Liou, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022814 · Cited by 61
Su, Y., Jiang, X., Li, Y., Li, F., Cheng, Y., Peng, Y. H., Song, D., Hong, J., Ning, G., Cao, Y., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1167 · Cited by 57
Jiang, J., Fan, Y., Zhang, W., Shen, Y., Liu, T., Yao, M., Gu, J., Tu, H., & Gan, Y. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.27420 · Cited by 57
“Cyclin D1has been proven to promote the transition from G1 phase to S phase and is mandatory for cell proliferation [23, 24].”
BackgroundTwo Arabidopsis cyclin A3s possess G1 cyclin-like features
Takahashi, I., Kojima, S., Sakaguchi, N., Umeda‐Hara, C., & Umeda, M. (2010) · Plant Cell Reports · doi:10.1007/s00299-010-0817-9 · Cited by 53
“Mitogen-induced signals stimulate cyclin D-CDK complexes at multiple levels, including those of gene transcription, translation, protein stability, and assembly and import of these complexes into the nucleus (Sherr and Roberts 2004).”
BackgroundMaissan, P., Mooij, E., & Barberis, M. (2021) · Biology · doi:10.3390/biology10030194 · Cited by 48
New Approaches to Target T-ALL
Roti, G., & Stegmaier, K. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00170 · Cited by 57
New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort
Hoffman, A., Lazar, A. J., Pollock, R. E., & Lev, D. C. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.11.001 · Cited by 59
Tipping the Balance: Cdk2 Enables Myc to Suppress Senescence
Hydbring, P., & Larsson, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1383 · Cited by 56
Characterization of cytoplasmic cyclin D1 as a marker of invasiveness in cancer
Fusté, N. P., Castelblanco, E., Felip, I., Santacana, M., Fernández-Hernández, R., Gatius, S., Pedraza, N., Pallarés, J., Cemeli, T., Valls, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8876 · Cited by 53
“The Ccnd1·Cdk4 complex phosphorylates the transcriptional repressor pRB releasing the E2F-dependent transcription required for S phase entry [8].”
BackgroundInhibitors of cyclin-dependent kinase modulators for cancer therapy
Senderowicz, A. M. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7414-4_8 · Cited by 61
Lee, H., Jedrychowski, M. P., Vinayagam, A., Wu, N., Shyh‐Chang, N., Hu, Y., Min-Wen, C., Moore, J. K., Asara, J. M., Lyssiotis, C. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.074 · Cited by 56
“1F) (Malumbres and Barbacid, 2005; Murray, 2004; Sherr and Roberts, 2004).”
Shin, H. J., Kim, I. S., Choi, S. G., Lee, K., Park, H., Shin, J., Kim, D., Beom, J., Yi, Y. Y., Gupta, D. P., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00715-x · Cited by 55
“…whether the cell cycle of microglia can be controlled by decreasing the expression of p16 ink4a through siRNA capsulated PLGA NPs. P16 ink4a specifically inhibits cyclin-dependent kinases 4 and 6 (CDK4, CDK6)-mediated phosphorylation of p-Rb, consequently blocking cell cycle progression [43].”
BackgroundCCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells
Pervaiz, A., Ansari, S. S., Berger, M. R., & Adwan, H. (2015) · Medical Oncology · doi:10.1007/s12032-015-0607-x · Cited by 51
“In this regard, two important CDKs are CDK4 and CDK6, which are required for G1/S phase transition of the cell cycle [35, 36].”
BackgroundRay, J. E., Garcia, J., Jurisicova, A., & Caniggia, I. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.167 · Cited by 50
Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia
Toriellec, É. L., Despouy, G., Pierron, G., Gaye, N., Joiner, M., Bellanger, D., Vincent‐Salomon, A., & Stern, M. (2007) · Blood · doi:10.1182/blood-2007-06-095570 · Cited by 50
“The specific consequence of CDKN1B alterations with regards to tumor progression may be attributed to the complicated role of its product on the cell cycle, depending on its cellular concentration.(13) We generated a mouse model of human T-PLL by crossing MTCP1 mice with Cdkn1b mice in order to search for a putative h…”
BackgroundTwo-way traffic: centrosomes and the cell cycle
Sluder, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1712 · Cited by 50
Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells
Pasder, O., Shpungin, S., Salem, Y., Makovski, A., Vilchick, S., Michaeli, S., Malovani, H., & Nir, U. (2006) · Oncogene · doi:10.1038/sj.onc.1209695 · Cited by 51
“S regulatory components, like CDK4 and CDK2 (Berthet et al., 2003; Ortega et al., 2003; Tetsu and McCormick, 2003; Malumbres et al., 2004; Sherr and Roberts, 2004).”
BackgroundAn update on the implications of cyclin D1 in melanomas
González‐Ruiz, L., González‐Moles, M. Á., González‐Ruiz, I., Ruiz‐Ávila, I., Ayén, Á., & Ramos‐García, P. (2020) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12874 · Cited by 49
“(K) Finally, the combination of BRaf inhibitors with CDK4/6 inhibitors (e.g., palbociclib and vemurafenib) is currently under clinical trial, with reports that it may overcome acquired resistance to treatment based on anti-BRaf inhibitors alone and may offer greater effectiveness than the sum of each therapy individua…”
BackgroundTargeting CDK4/6 for Anticancer Therapy
Qi, J., & Ouyang, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10030685 · Cited by 53
“Among the four CDKs linked to mitosis, CDK1 alone is enough to drive the cell cycle, while CDK2 and CDK4/6 are only indispensable in cell proliferation of specific cells [4,24].”
BackgroundCDK4/6 inhibitors in breast cancer
Dukelow, T., Kishan, D., Khasraw, M., & Murphy, C. G. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000249 · Cited by 54
Jiang, R., & Lönnerdal, B. L. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.002 · Cited by 55
Castoria, G., Giovannelli, P., Donato, M. D., Ciociola, A., Hayashi, R., Bernal, F., Appella, E., Auricchio, F., & Migliaccio, A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.497 · Cited by 49
“Neither 10 nM nor 1 pM R1881 modifies p27 transcription in gene reporter assay, whereas serum stimulation of quiescent NIH3T3 fibroblasts increases (about fourfold) p27 transcription (Supplementary Figures 3S A). p27 is localized in the nuclei of quiescent cells and is exported in cytoplasm as the cells progress towar…”
BackgroundInfluentialRegulating mitosis and meiosis in the male germ line: critical functions for cyclins
Wolgemuth, D. J., & Roberts, S. S. (2010) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0254 · Cited by 60
Cell Cycle Regulation During Proliferation and Differentiation of Mammalian Muscle Precursor Cells
Ciemerych, M. A., Archacka, K., Grabowska, I., & Gawor, M. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-19065-0_20 · Cited by 51
Role of key regulators of the cell cycle in maintenance of hematopoietic stem cells
Matsumoto, A., & Nakayama, K. I. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.004 · Cited by 60
Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis
Casimiro, M. C., Di Sante, G., Crosariol, M., Loro, E., Dampier, W., Ertel, A., Yu, Z., Saria, E. A., Papanikolaou, A., Li, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3267 · Cited by 45
Tumor-suppressive effects of CDK8 in endometrial cancer cells
Gu, W., Wang, C., Li, W., Hsu, F.-N., Tian, L., Zhou, J., Yuan, C., Xie, X.-J., Jiang, T., Addya, S., et al. (2013) · Cell Cycle · doi:10.4161/cc.24003 · Cited by 51
“Many studies in the past three decades have provided significant insights into understanding the roles of several CDKs, such as CDK1, CDK2, CDK4 and CDK6, in regulating cell proliferation and how dysregulation of these CDKs and their regulatory cyclins contributes to tumorigenesis.(2,4,5) However, much less is known a…”
BackgroundAberrant Expression of Cyclin D1 in Cancer
Inoue, K., & Fry, E. A. (2015) · Signal Transduction Insights · doi:10.4137/sti.s30306 · Cited by 51
“The cyclin D-Cdk4/6 complexes activate cyclin E/Cdk2 through titration of the Cdk inhibitors p21Cip1/p27Kip1.”
BackgroundInfluentialCyclin D1 Inhibits Mitochondrial Activity in B Cells
Tchakarska, G., Roussel, M., Troussard, X., & Sola, B. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2564 · Cited by 42
“protein and thus abolishing its transcriptional repressive activity and promoting cell cycle progression (1).”
Sicinska, E., Lee, Y.-M., Gits, J., Shigematsu, H., Yu, Q., Rebel, V. I., Geng, Y., Marshall, C. J., Akashi, K., Dorfman, D. M., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00800-06 · Cited by 45
Badía, R., Angulo, G., Riveira‐Muñoz, E., Pujantell, M., Puig, T., Ramirez, C., Torres‐Torronteras, J., Martí, R., Pauls, E., Clotet, B., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv363 · Cited by 46
Gul, A., Leyland-Jones, B., Dey, N., & De, P. K. (2018) · Europe PMC (PubMed Central) · Cited by 48
Kundumani‐Sridharan, V., Singh, N. K., Kumar, S., Gadepalli, R., & Rao, G. N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454082 · Cited by 48
“NFATc1, via Enhancing Cyclin D1-CDK6/4 Signaling, Mediates MCP1-induced Pak1 Activation—Activation of CDKs requires type D cyclins (21).”
BackgroundCaligiuri, M., Becker, F., Murthi, K. K., Kaplan, F., Dédier, S., Kaufmann, C. M., Machl, A., Zybarth, G., Richard, J., Bockovich, N., et al. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.08.008 · Cited by 45
Cdk5 and the non-catalytic arrest of the neuronal cell cycle
Zhang, J., & Herrup, K. (2008) · Cell Cycle · doi:10.4161/cc.7.22.7045 · Cited by 44
Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
Gao, Y., Yu, Y., Zhang, M., Yu, W., & Kang, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1448687 · Cited by 50
Li, O., Ferreira, A. M., Otieno, S. B., 利民, L. X. 肖., Bashford, D., & Kriwacki, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244095 · Cited by 44
Bustany, S., Cahu, J., Guardiola, P., & Sola, B. (2015) · BMC Cancer · doi:10.1186/s12885-015-1240-y · Cited by 44
“This is consistent with the well known function of cyclin D1 in cell cycle regulation through cyclin-dependent kinase 4/6 activation [3].”
Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia
Bride, K. L., Hu, H., Tikhonova, A. N., Fuller, T. J., Vincent, T. L., Shraim, R., Li, M. M., Carroll, W. L., Raetz, E. A., Aifantis, I., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279410 · Cited by 49
“In complex with cyclin D, CDK4/6 promote cell cycle progression through at least two functions: hyper-phosphorylation of the retinoblastoma protein (RB) thereby uncoupling the CDK4/6-cyclin D complex from the E2F transcription factors; and interaction with cell cycle inhibitors, p21 and p27, which promotes activation…”
Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma
Radulovich, N., Pham, N., Strumpf, D., Leung, L., Xie, W., Jurišica, I., & Tsao, M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-24 · Cited by 44
“embryogenesis, growth and differentiation) as well as in carcinogenesis [8].”
BackgroundWeiss, G. J., Hidalgo, M. M., Borad, M. J., Laheru, D. A., Tibes, R., Ramanathan, R. K., Blaydorn, L., Jameson, G., Jimeno, A., Isaacs, J. D., et al. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9774-6 · Cited by 47
“Cyclin-dependent kinases (CDKs) are serine/threonine kinases that, in concert with their positive and negative regulators, play a crucial role in cell cycle progression [10].”
Age-dependent kinetics of dentate gyrus neurogenesis in the absence of cyclin D2
Ansorg, A., Witte, O. W., & Urbach, A. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-46 · Cited by 41
“Studies from knock out mice with deletions of one, two, or all G1 cyclins revealed remarkably normal morphogenesis at least until midgestation (reviewed in [16]), indicating a considerable degree of functional redundancy and compensatory capacity [17-23].”
BackgroundMoldrich, R. X., Dauphinot, L., Laffaire, J., Vitalis, T., Hérault, Y., Beart, P. M., Rossier, J., Vivien, D., Gehrig, C., Antonarakis, S. E., et al. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22131 · Cited by 43
MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2
Gillam, M. P., Nimbalkar, D., Sun, L., Christov, K. T., Ray, D., Kaldis, P., Liu, X., & Kiyokawa, H. (2014) · Oncogene · doi:10.1038/onc.2014.3 · Cited by 45
Regulation of p27Kip1 phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G.
Sun, C., Wang, G., Wrighton, K. H., Lin, H., Songyang, Z., Feng, X., & Lin, X. (2016) · PubMed · Cited by 56
Luo, J., Yan, R., He, X., & He, J. (2017) · PubMed · Cited by 55
PD-1/PD-L1 Axis as a Potential Therapeutic Target for Multiple Sclerosis: A T Cell Perspective
Li, H., Zheng, C., Han, J., Zhu, J., Liu, S., & Jin, T. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.716747 · Cited by 52
Lipid Phosphate Phosphatase-2 Activity Regulates S-phase Entry of the Cell Cycle in Rat2 Fibroblasts
Morris, K., Schang, L. M., & Brindley, D. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511710200 · Cited by 48
Structural characterization of the cyclin-dependent protein kinase family
Endicott, J., & Noble, M. E. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130097 · Cited by 46
Ferguson, B. S., Nam, H., & Morrison, R. F. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.11.014 · Cited by 42
“Transition through the G1/S phase restriction point represents a pivotal and decisive point of cellular autonomy where cell cycle control becomes mitogen-independent [4,37,38].”
Li, L., Piloto, O., Kim, K., Ye, Z., Nguyen, H. B., Yu, X., Levis, M. J., Cheng, L., & Small, D. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06525.x · Cited by 46
“In this study, c-Myc expression was also upregulated in FLT3/ ITD-transduced HSPCs. CCND3 is a member of the Cyclin D subfamily that interacts with CDK4/CDK6 protein kinase to form a serine/threonine kinase holoenzyme complex (Berns et al, 1997; Sherr & Roberts, 2004).”
BackgroundInfluentialProlyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis
Chen, H.-Z., Li, L., Wang, W.-J., Du, X.-D., Wen, Q., He, J., Zhao, B.-X., Li, G.-D., Zhou, W., Xia, Y. F., et al. (2011) · Oncogene · doi:10.1038/onc.2011.463 · Cited by 46
“Cyclin D2 is a D-type cyclin that promotes the activity of CDK4 and CDK6, and thus accelerates G1 progression of cultured mammalian cells (Sherr and Roberts, 2004).”
BackgroundTamamori‐Adachi, M., Takagi, H., Hashimoto, K., Goto, K., Hidaka, T., Koshimizu, U., Yamada, K., Goto, I., Maejima, Y., Isobe, M., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn183 · Cited by 42
“Progression of the mammalian cell cycle is regulated by a combination of positive and negative regulators, cyclins and cyclin-dependent kinases (CDKs) and CDK inhibitors (CDKIs).(20,21) During the G1 phase, cyclin D1 and other D-type cyclins assemble with their catalytic partners, CDK4 and CDK6, and accumulate in the…”
BackgroundYoon, D.-K., Jeong, C., Jun, H. O., Chun, K., Cha, J., Seo, J. H., Lee, H., Choi, Y. K., Ahn, B. J., Lee, S.-K., et al. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.02.017 · Cited by 44
“The CDKIs regulate the progression of cells in the G0/G1 phase of cell cycle and induction of Cip1/p21 and Kip1/p27 causes a blockade of the G1 to S transition, thereby participating in cell cycle regulation [12].”
BackgroundCyclin D1 and cyclin E2 are differentially expressed in gastric cancer
Kumari, S., Puneet, Prasad, S. B., Yadav, S. S., Kumar, M., Khanna, A. K., Dixit, V. K., Nath, G., Singh, S., & Narayan, G. (2016) · Medical Oncology · doi:10.1007/s12032-016-0754-8 · Cited by 44
Zhou, L.-Y., Liu, R., Liang, X., Zhang, S., Bi, W., Yang, M., He, Y., Jin, J., Li, S., Yang, X., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.017 · Cited by 43
“The CDK4/cyclin D1 complexes phosphorylate and inactivate a tumor suppressor protein retinoblastoma (RB), leading to the release of E2F transcription factor that regulates expression of genes necessary for entry and progression through the S phase.(33) CDK4 has been identified as the major oncogenic driver among the c…”
Shimizu, T., Ho, L., & Lai, Z.-C. (2008) · Genetics · doi:10.1534/genetics.107.081570 · Cited by 46
“Cyclin E is a critical cell cycle regulator (Sherr and Roberts 2004).”
BackgroundCutaneous vasculitis in breast cancer treated with chemotherapy
Wong, M., Grossman, J., Hahn, B. H., & Cava, A. L. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.001 · Cited by 42
“High levels of HER2 are associated with poor prognosis and high resistance to chemotherapy and hormone therapy, high relapse rate, and reduced survival [21,22].”
BackgroundIntron-Mediated RNA Interference, Intronic MicroRNAs, and Applications
Ying, S.-Y., Chang, C. P., & Lin, S.-L. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-657-3_14 · Cited by 37
Gene regulatory network underlying the immortalization of epithelial cells
Méndez-López, L. F., Dávila-Velderrain, J., Domínguez‐Hüttinger, E., Enríquez-Olguín, C., Martínez‐García, J. C., & Alvarez-Buylla, E. R. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0393-5 · Cited by 43
“While both E2F [21] and cyclins [22] are required for cell cycle progression, the tumor suppressor Rb acts as an inhibitor of this process by forming an inactive heteromer with E2F [23].”
Karpurapu, M., Wang, D., Singh, N. K., Li, Q., & Rao, G. N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800423200 · Cited by 47
Yue, W., Zhao, X., Zhang, L., Xu, S., Liu, Z., Ma, L., Jia, W., Qian, Z., Zhang, C., Wang, Y., et al. (2011) · Clinical Lung Cancer · doi:10.3816/clc.2011.n.006 · Cited by 40
Regulation of the Embryonic Cell Cycle During Mammalian Preimplantation Development
Palmer, N., & Kaldis, P. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.05.001 · Cited by 41
A review for clinicians: Prostate cancer and the antineoplastic properties of metformin
Hankinson, S. J., Fam, M. M., & Patel, N. N. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.10.009 · Cited by 41
Kumar, R., Awasthi, M., Sharma, A., Padwad, Y. S., & Sharma, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117346 · Cited by 42
Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
Nagabushan, S., Lau, L. M. S., Barahona, P., Wong, M., Sherstyuk, A., Marshall, G. M., Tyrrell, V. J., Wegner, E. A., Ekert, P. G., Cowley, M. J., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00145-8 · Cited by 40
Anticancer Mechanisms of Bioactive Compounds from Solanaceae: An Update
Nkwe, D. O., Lotshwao, B., Rantong, G., Matshwele, J. T. P., Kwape, T. E., Masisi, K., Gaobotse, G., Hefferon, K. L., & Makhzoum, A. B. (2021) · Cancers · doi:10.3390/cancers13194989 · Cited by 45
Imidazole-4,5-dicarboxamide Derivatives with Antiproliferative Activity against HL-60 Cells
Perchellet, E. M., Perchellet, J., & Baures, P. W. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050160r · Cited by 40
Canonical pathways and networks regulated by estrogen in the bovine mammary gland
Li, R. W., & Capuco, A. V. (2007) · Functional & Integrative Genomics · doi:10.1007/s10142-007-0055-6 · Cited by 40
“The lack of induction of cyclin D (D1, D2, and D3) and its specific partners CDK4 and CDK6 by estrogen and the induction of CDK2 and both G1/S and G2/M pathways impacted by estrogen suggest that cyclin E/A-CDK2 complexes may play a more important role in estrogen-stimulated cell-cycle progression in cattle.”
BackgroundInfluentialXue, L., Chiang, L., He, B., Zhao, Y., & Winoto, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009229 · Cited by 43
Cyclin D1 promotes anchorage-independent cell survival by inhibiting FOXO-mediated anoikis
Gan, L., Liu, P., Lu, H., Chen, S., Yang, J., McCarthy, J. B., Knudsen, K. E., & Huang, H. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.86 · Cited by 44
“Cyclin D1 promotes transit through the cell cycle by binding to and activating CDK4 and CDK6, resulting in phosphorylation and inactivation of the tumor suppressor protein RB.18 However, increasing evidence suggests that a CDK4/6-independent function of cyclin D1 may also be important for tumorigenesis.19 In support o…”
InfluentialThe molecular genetics of breast cancer and targeted therapy.
Suter, R., & Marcum, J. A. (2007) · PubMed Central · Cited by 56
Cyclers’ kinases in cell division: from molecules to cancer therapy
Milletti, G., Colicchia, V., & Cecconi, F. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01196-z · Cited by 39
“Simultaneously, KIP/CIP proteins are inhibitors of CDK2 and CDK1 activity [10].”
BackgroundFan, H., Liu, W., Zeng, Y., Zhou, Y., Gao, M., Yang, L., Liu, H., Shi, Y., Li, L., Ma, J., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05412-x · Cited by 42
“Among the cyclins, D-type cyclins (D1, D2 and D3) can interact with CDK4 and CDK6 4 , a pair of cell cycle kinases that are similar in structure and function, mediating cell cycle transition from G0/G1-phase to S-phase 4,5 .”
Klein, B., Seckinger, A., Moehler, T. M., & Hose, D. (2011) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-85772-3_3 · Cited by 46
Sadeu, J. C., & Foster, W. G. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.05.008 · Cited by 39
Singh, N. K., Kundumani‐Sridharan, V., Kumar, S., Verma, S. K., Kotla, S., Mukai, H., Heckle, M., & Rao, G. N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.361220 · Cited by 40
“An established role of cyclin D1-CDK4/6 is their involvement in G1-S phase transition of a cell in response to a mitogen (39-41).”
BackgroundCao, Z., Zhang, R., Li, J., Huang, H., Zhang, D., Zhang, J., Gao, J., Chen, J., & Huang, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448365 · Cited by 40
“D-type cyclins are believed to serve as links between the extracellular environment and the core cell cyclemachinery (51, 52).”
BackgroundSenescence Inducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression
Zheng, H., Huang, Q., Huang, S., Yang, X., Zhu, T., Wang, W., Wang, H., He, S., Ji, L., Wang, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00519 · Cited by 40
“Moreover, given the significant G0/G1 arrest in A549 and H1299 cells, cyclin D1, a key protein required for progression through the G1 phase of the cell cycle (Sherr and Roberts, 2004) was further determined.”
BackgroundOsborn, S. L., Sohn, S. J., & Winoto, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703163200 · Cited by 39
IL‐4 blocks M‐CSF‐dependent macrophage proliferation by inducing p21Waf1 in a STAT6‐dependent way
Arpa, L., Valledor, A. F., Lloberas, J., & Celada, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200838283 · Cited by 39
Yu, J., Ding, S.-L., Chang, C., Kuo, S.-H., Chen, S., Hsu, G., Hsu, H.-M., Hou, M., Jung, L. Y., Cheng, C., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp173 · Cited by 40
Wang, L., Zhang, R., You, X., Zhang, H., Wei, S., Cheng, T., Cao, Q., Wang, Z., & Chen, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx028 · Cited by 41
“The CDK4/cyclin D complexes phosphorylate and inactivate a tumor suppressor protein retinoblastoma (RB), leading to release of E2F transcription factors that regulate expression of genes necessary for entry and progression through the S phase (Sherr and Roberts, 2004).”
BackgroundEpigenetic regulation of skin: focus on the Polycomb complex
Zhang, J., Bardot, E., & Ezhkova, E. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0920-x · Cited by 39
“Ink4a and Ink4b genes encode the p16 and p15 inhibitors of the G1/S phase of the cell cycle, and Arf encodes the p19 inhibitor of the p53 suppressor MDM2 [73].”
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.